Indi (Integrated Dx) (@IntegratedDx) header
Indi (Integrated Dx) (@IntegratedDx) profile picture

Indi (Integrated Dx)

@IntegratedDx

Xpresys Lung is a molecular blood test developed to provide non-invasive, objective information for assessment of pulmonary nodules.

 Seattle, WA
IndiDx.com
Joined June 2012
  • Tweets41
  • Following7
  • Followers62
In Tough Diagnostics World, Will Ruling Out Cancer Be Good Business? | in depth Xconomy column by @AlexLash ow.ly/QzZ6M
Today CHEST Physician published a story about our recent study of benign lung nodules ow.ly/OQuYl
1
New Indi landmark study in CHEST suggests there may be overtreatment of benign lung nodules ow.ly/Oufvn
Indi Publishes Technical Paper on Methods to Improve Reproducibility and Robustness of MRM-Mass Spec Proteomic Tests ow.ly/KsMoL
"A very elegant approach" Indi Publishes Details of Assay Variability Controls Used in Xpresys Lung | GenomeWeb ow.ly/JZy2X

Indi Publishes Details of Assay Variability Controls Used in Xpresys Lung Mass Spec Workflow

The MRM-MS-based method combines use of conventional stable isotope-labeled peptide standards with a series of endogenous protein standards.

genomeweb.com
1
Indi Announces Agreement to License Xpresys Lung in Canada to Caprion | ow.ly/IpzMH | cc:@CaprionProteome
Landmark Indi Publication Shows Xpresys Lung Helps Identify Benign Lung Nodules |ow.ly/Ia66Y
Indi (Integrated Dx) retweeted
Ben Fidler (@BentheFidler) profile picture
Ben Fidler@BentheFidler5 Nov 2014
In Short Order, Indi Convinces Insurers To Cover Its Lung Test xconomy.com/seattle/2014/11/… by @alexlash @IntegratedDx
2
2
Indi Secures Contracts for Xpresys Lung with MultiPlan and Five Other PPOs | Release | ow.ly/DPZCS
Blood Test for Pulmonary Nodules Now Available to 200 Million Covered Lives | Release | indidx.com/indi_announces_un…
Come meet Dr. Alexander Porter at #Chest2014 Booth 1731 and learn more about Xpresys Lung ow.ly/DiEhC #LungCancer
Xpresys Lung has only one complication, a bandage. Learn more at #Chest2014 Booth 1731 ow.ly/DiEhC #LungCancer
If you're heading to Life Science Innovation Northwest 2014 @Washbio - come hear @IntegratedDx CEO Dr. Al Luderer speak this Friday |...
Wondering how to build a sustainable Dx company? Come hear Indi CEO Dr. Al Luderer speak at #BIO2014 goo.gl/lh56Pe
Headed to #ATS2014? Come hear presentations on Xpresys Lung and Lung Nodule Management. goo.gl/ucIOU9 #proteomics #lungcancer
1
Indi Raises $47 Million for Dx to Help Doctors Better Assess Lung Nodules | Release | goo.gl/kMTUuv #proteomics
Indi Raises $47 Million for Dx to Help Doctors Better Assess Lung Nodules | goo.gl/kMTUuv #diagnostics #proteomics #lungcancer
1
At MSACL 2014, Advances in MS-based Clinical Proteomics...Starting with Xpresys Lung | @ProteoMonitor | #Proteomics | GenomeWeb...
Heading to Leerink Global Healthcare 2014? Come hear about the next blockbuster diagnostic from Indi's CEO, Al Luderer.
Cancer Genomics Enters a New Era | @ISBLeeHood in GEN mag on Blood-based Dx and Xpresys Lung | ow.ly/tffEN
Load more